FOLH1 and cancer: Additionally, in a subset of human patients with clinically undetectable prostatic pathology, RT-PCR for PSMA was predictive of future cancer recurrence and metastasis development [28, 29]; findings that highlight the potential value of PSMA amplicon detection for the surveillance of minimal residual disease burden.